During the past decade, CHU Clemenceau conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Clemenceau" #1 sponsor was "Groupe Francophone des Myelodysplasies" with 4 trials, followed by "Chiesi Farmaceutici S.p.A." with 2 trials sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored, "Associazione Qol-one" with 1 trials sponsored and "Centre Hospitalier Universitaire de Nice" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Clemenceau" #1 collaborator was "Roche Pharma AG" with 3 trials as a collaborator, "ARAIRLOR" with 1 trials as a collaborator, "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "CHUGAI sanofi-aventis" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "CHU Clemenceau" are "Myelodysplastic Syndromes" (4 trials), "Cystic Fibrosis" (2 trials), "Renal Transplantation" (2 trials), "Anaemia" (1 trials) and "Aplastic Anaemia" (1 trials). Many other conditions were trialed in "CHU Clemenceau" in a lesser frequency.

Most popular intervention types in "CHU Clemenceau" are "Drug" (15 trials), "Other" (3 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin beta" (2 trials), "Air" (1 trials), "Azacitidine" (1 trials), "Calcium acetate (PhosLo® )" (1 trials) and "Curosurf" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Clemenceau" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CHU Clemenceau". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in CHU Clemenceau, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Clemenceau, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".